Abstract
Three novel triazines series were prepared. These series are pyrazolines (4a and 4b), pyrazoles (6a, 6b and 8a-d) and isoxazoles (7a and 7b). Such series were designed as COX-2 inhibitors. All compounds were characterized by using spectroscopic methods and elemental analysis. Regarding COX-2, compounds 5b, 4a and 3b were the most active with IC50 in the range of 0.55-0.87 μM. Most of synthesized compounds were relatively more potent to celecoxib (0.78 μM), diclofenac (2.94 μM) and indomethacin (7.24 μM). A molecular modeling study was performed for the most active compounds. Histopathological evaluation also was done to estimate the safety of compounds. Finally, structure elucidation of pyrazole 8 was studied by 2D NMR.
Keywords:
Anti-inflammatory activity; COX-2 inhibitors; Enaminone; HMBC; Histopathology; S-Triazines.
Copyright © 2016. Published by Elsevier Masson SAS.
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
-
Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis*
-
Anti-Inflammatory Agents, Non-Steroidal / metabolism
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
-
Chemistry Techniques, Synthetic
-
Cyclization
-
Cyclooxygenase 2 / chemistry
-
Cyclooxygenase 2 / metabolism
-
Cyclooxygenase 2 Inhibitors / adverse effects
-
Cyclooxygenase 2 Inhibitors / chemical synthesis*
-
Cyclooxygenase 2 Inhibitors / metabolism
-
Cyclooxygenase 2 Inhibitors / pharmacology*
-
Drug Design
-
Male
-
Molecular Docking Simulation
-
Protein Conformation
-
Pyrazoles / chemistry*
-
Rats
-
Stereoisomerism
-
Structure-Activity Relationship
-
Triazines / adverse effects
-
Triazines / chemical synthesis*
-
Triazines / metabolism
-
Triazines / pharmacology*
-
Ulcer / chemically induced
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Cyclooxygenase 2 Inhibitors
-
Pyrazoles
-
Triazines
-
Cyclooxygenase 2